Business

Workers reject Boeing's latest offer after nearly three months on strike

Workers reject Boeing's latest offer after nearly three months on strike

By Dan Catchpole (Reuters) -Striking workers at Boeing Defense in the St. Louis area rejected the company's latest contract proposal…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025

Novartis to acquire Avidity Biosciences for about $12 billion

By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025

Novartis to acquire Avidity Biosciences for $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. (Reporting by Angela Christy…

October 27, 2025

Novartis to acquire Avidity Biosciences for about $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion…

October 26, 2025

Air traffic controller shortages emerge, US transportation secretary says

By Idrees Ali and David Shepardson WASHINGTON (Reuters) -U.S. airports reported more than 20 incidents of air traffic controller shortages…

October 26, 2025

Workers reject Boeing's latest offer after nearly three months on strike

By Dan Catchpole (Reuters) -Striking workers at Boeing Defense in the St. Louis area rejected the company's latest contract proposal…

October 26, 2025

US, China talks sketch out rare earths, tariff pause for Trump and Xi to consider

By Xinghui Kok KUALA LUMPUR (Reuters) -Top Chinese and U.S. economic officials on Sunday hashed out the framework of a…

October 26, 2025

Novartis to acquire Avidity Biosciences for about $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion…

October 26, 2025